KR20090048393A - 특정 폴리사카라이드에 의해 속쓰림 및 위-식도 역류 질환(gerd)의 증상을 감소시키는 방법 - Google Patents

특정 폴리사카라이드에 의해 속쓰림 및 위-식도 역류 질환(gerd)의 증상을 감소시키는 방법 Download PDF

Info

Publication number
KR20090048393A
KR20090048393A KR1020087030557A KR20087030557A KR20090048393A KR 20090048393 A KR20090048393 A KR 20090048393A KR 1020087030557 A KR1020087030557 A KR 1020087030557A KR 20087030557 A KR20087030557 A KR 20087030557A KR 20090048393 A KR20090048393 A KR 20090048393A
Authority
KR
South Korea
Prior art keywords
polysaccharide
formulation
acid
viscosity
minutes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020087030557A
Other languages
English (en)
Korean (ko)
Inventor
마리아 안나 베르부르겐
칼빈 티 켈리
블레인 쥐 수돔
Original Assignee
프루타롬 네덜란드 비.브이.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 프루타롬 네덜란드 비.브이. filed Critical 프루타롬 네덜란드 비.브이.
Publication of KR20090048393A publication Critical patent/KR20090048393A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • A61K31/718Starch or degraded starch, e.g. amylose, amylopectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • A61K31/722Chitin, chitosan
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • A61K31/724Cyclodextrins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/731Carrageenans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/732Pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/736Glucomannans or galactomannans, e.g. locust bean gum, guar gum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/738Cross-linked polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Plant Substances (AREA)
KR1020087030557A 2006-05-16 2007-05-16 특정 폴리사카라이드에 의해 속쓰림 및 위-식도 역류 질환(gerd)의 증상을 감소시키는 방법 Ceased KR20090048393A (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP06076056.8 2006-05-16
EP06076056A EP1859786A1 (en) 2006-05-16 2006-05-16 A method to reduce the symptoms of heartburn and gastro-oesophageal reflux disease (GERD) by specific polysaccharides
US80631306P 2006-06-30 2006-06-30
US60/806,313 2006-06-30

Publications (1)

Publication Number Publication Date
KR20090048393A true KR20090048393A (ko) 2009-05-13

Family

ID=37806824

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020087030557A Ceased KR20090048393A (ko) 2006-05-16 2007-05-16 특정 폴리사카라이드에 의해 속쓰림 및 위-식도 역류 질환(gerd)의 증상을 감소시키는 방법

Country Status (9)

Country Link
US (2) US20090252792A1 (https=)
EP (2) EP1859786A1 (https=)
JP (1) JP2009537512A (https=)
KR (1) KR20090048393A (https=)
AT (1) ATE514415T1 (https=)
AU (1) AU2007250624B2 (https=)
RU (1) RU2432167C2 (https=)
TW (1) TWI402074B (https=)
WO (1) WO2007133082A1 (https=)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011135107A1 (es) 2010-04-26 2011-11-03 Angel Manuel Gago De Santos Composiciones para el alivio sintomático del dolor de estómago o reflujo gastroesofágico
WO2022240224A1 (ko) * 2021-05-14 2022-11-17 한국식품연구원 젤란검을 유효성분으로 하는 장내 균총 개선용 조성물 및 이를 포함하는 대사성 질환 개선, 예방 또는 치료용 조성물

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090148530A1 (en) * 2007-12-08 2009-06-11 Jamie Koufman Method for prevention and treatment of reflux injury in the aerodigestive tract and laryngopharynx caused by pepsin
EP2346351B1 (en) 2008-09-22 2019-07-03 Rubicon Research Private Limited Compositions exhibiting delayed transit through the gastrointestinal tract
ITRM20120041A1 (it) * 2012-02-08 2013-08-09 Dicofarm Spa "prodotto a base di glucomannano e chitosano utile per il trattamento del reflusso gastroesofageo"
ITRM20120084A1 (it) * 2012-03-07 2013-09-08 Aboca Spa Societa Agricola Miscela prebiotica.
EP2827839B1 (en) 2012-03-20 2019-02-27 Particle Dynamics International, LLC Gelling agent-based dosage form
ITMI20130960A1 (it) * 2013-06-11 2014-12-12 Novintethical Pharma Sagl Composizioni a base di xiloglucano per il trattamento di disturbi gastrointestinali
IT201700091733A1 (it) * 2017-08-08 2019-02-08 Neilos S R L Composizione per somministrazione orale per uso nel trattamento terapeutico o preventivo dei disturbi o malattia da reflusso gastroesofageo
JP2019064980A (ja) * 2017-10-03 2019-04-25 小林製薬株式会社 逆流性食道炎改善剤
AU2019312160B2 (en) 2018-07-23 2024-02-22 Nutragenom, Llc Composition and methods for generating and sustaining molecular hydrogen (H2) in aqueous systems
CN111227156A (zh) * 2020-01-20 2020-06-05 陕西科技大学 一种抑制反酸的固体饮料及其制备方法
TWI777673B (zh) * 2021-07-16 2022-09-11 陳昭誠 由β-1-4-葡聚醣形成之纖維於製備用於治療或預防胃食道逆流之組成物之用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3152319C2 (de) * 1980-09-03 1986-05-07 Kyosei Pharmaceutical Co., Ltd., Hokkaido Verwendung einer Lösung eines Salzes der Alginsäure zur Behandlung von Strahlenschäden und Ulcera
IL108583A (en) * 1994-02-07 1997-06-10 Yissum Res Dev Co Galactomannan emulsions and comestible products containing the same
GB9708773D0 (en) * 1997-04-30 1997-06-25 Reckitt & Colmann Prod Ltd Organic compositions
CA2206157C (en) * 1997-05-26 2000-06-13 Cheng, Peter Method of extraction of commercially valuable fractions of fenugreek
GB9910212D0 (en) * 1999-05-05 1999-06-30 Reckitt & Colmann Prod Ltd Improvements in or relating to organic compositions
GB0005743D0 (en) * 2000-03-10 2000-05-03 Reckitt & Colmann Prod Ltd Pharmaceutical compositions including alginates
GB2384986B (en) * 2002-02-12 2004-01-07 Reckitt Benckiser Healthcare Compositions for the treatment of disorders of the upper gastrointestinal tract
CN1780880B (zh) * 2003-04-25 2010-04-28 雷克特本克斯尔保健(英国)有限公司 可增稠的组合物
ATE390142T1 (de) * 2003-05-14 2008-04-15 Indus Biotech Pvt Ltd Synergistische zusammensetzung zur behandlung von diabetes mellitus

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011135107A1 (es) 2010-04-26 2011-11-03 Angel Manuel Gago De Santos Composiciones para el alivio sintomático del dolor de estómago o reflujo gastroesofágico
WO2022240224A1 (ko) * 2021-05-14 2022-11-17 한국식품연구원 젤란검을 유효성분으로 하는 장내 균총 개선용 조성물 및 이를 포함하는 대사성 질환 개선, 예방 또는 치료용 조성물

Also Published As

Publication number Publication date
RU2008149527A (ru) 2010-06-27
US20090252792A1 (en) 2009-10-08
EP2026763A1 (en) 2009-02-25
TWI402074B (zh) 2013-07-21
JP2009537512A (ja) 2009-10-29
AU2007250624B2 (en) 2012-09-20
WO2007133082A1 (en) 2007-11-22
US20120231078A1 (en) 2012-09-13
TW200812596A (en) 2008-03-16
RU2432167C2 (ru) 2011-10-27
EP1859786A1 (en) 2007-11-28
AU2007250624A1 (en) 2007-11-22
ATE514415T1 (de) 2011-07-15
EP2026763B1 (en) 2011-06-29

Similar Documents

Publication Publication Date Title
KR20090048393A (ko) 특정 폴리사카라이드에 의해 속쓰림 및 위-식도 역류 질환(gerd)의 증상을 감소시키는 방법
CN102281887B (zh) 用于治疗胃-食管反流病(gerd)的组合物
US5989588A (en) Methods and compositions for preventing and treating heartburn
US20070202058A1 (en) Compositions for treating gastric reflux
EP3124048B1 (en) Composition for oral use in the treatment of gastro-oesophageal reflux disease or discomfort
EP2812009B1 (en) Product comprising glucomannan and chitosan for the treatment of gastroesophageal reflux disease
US20070203242A1 (en) Method for treating gastric reflux
KR101488921B1 (ko) 음용감이 우수한 소화기능 개선용 민트명수액 및 그 제조 방법
US11723939B2 (en) Composition for gastric and oesophageal diseases
EP4059506A1 (en) Composition for the treatment of reflux esophagitis and related symptoms
Yuspar Alginate as an Efficacious Treatment for GERD Patients: A Literature Review
EP1019066B1 (en) Methods and compositions for preventing and treating heartburn
EP4392041A1 (en) Composition for the prevention and/or treatment of gastric and esophageal diseases
US20240366707A1 (en) Composition for the prevention and/or treatment of gastric and esophageal diseases
WO2019030629A1 (en) COMPOSITION FOR ORAL ADMINISTRATION IN THERAPEUTIC OR PREVENTIVE TREATMENT OF DISORDERS OR DISEASE OF GASTROESOPHAGEAL REFLUX
Dorst Esophageal Reflux Disease
PT1019066E (pt) Métodos e composições para a prevenção e tratamento da azia

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20081215

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20120326

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20130729

Patent event code: PE09021S01D

E90F Notification of reason for final refusal
PE0902 Notice of grounds for rejection

Comment text: Final Notice of Reason for Refusal

Patent event date: 20140430

Patent event code: PE09021S02D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20141128

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20140430

Comment text: Final Notice of Reason for Refusal

Patent event code: PE06011S02I

Patent event date: 20130729

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I